Sort   by:  
 Page size 
UnknownClinical impact of COVID-19 on a French population of spondyloarthritis patients.
Not available
S-EPMC7511671 | biostudies-literature
UnknownImpact of Home Confinement During the COVID-19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients.
Not available
S-EPMC7323330 | biostudies-literature
UnknownImpact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study.
Not available
S-EPMC7953961 | biostudies-literature
UnknownEvaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study.
Not available
S-EPMC11749054 | biostudies-literature
UnknownSensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis.
Not available
S-EPMC10943808 | biostudies-literature
UnknownProtocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).
Not available
S-EPMC11624835 | biostudies-literature
UnknownResponse to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.
Not available
S-EPMC10339150 | biostudies-literature
UnknownRotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol.
Not available
S-EPMC11409346 | biostudies-literature
UnknownClinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
Not available
S-EPMC7598520 | biostudies-literature
UnknownRisk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Not available
S-EPMC2921546 | biostudies-literature
Sort   by:  
 Page size